aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Privo Technologies, founded in 2010 and based in Cambridge, United States, specializes in the manufacturing and processing of pharmaceutical preparations for both human and veterinary use. The company's core mission is to develop innovative therapeutics that eliminate cancers and prevent their recurrence, while making treatments more accessible and easier on patients. Privo Technologies offers a range of products under its PRV™ system, including PRV 111, PRV 131, and PRV 211, focusing on clinical trials and expanded access to cutting-edge cancer treatments.
Notable affiliated individuals include experts in pharmaceutical sciences and oncology, contributing to the company's robust research and development efforts. Privo Technologies has garnered attention from significant investors in the biotech sector, aiding in its growth and innovation. Key achievements include advancements in their PRV™ system and successful clinical trials, which have positioned the company as a promising player in the fight against cancer. Their impact is reflected in their commitment to providing hope through more effective and patient-friendly cancer treatments.
Operating Status
Active
Ownership Type(s)
Private
Main Product(s)
Pharmaceuticals
Technology
Biotech
Tags
Biotech, Healthtech
Model Types
Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
United States
When was Privo Technologies founded?
Privo Technologies was founded in 2016.
Where is Privo Technologies’s headquarters located?
Privo Technologies’s headquarters is located in Peabody, MA, US.
When was Privo Technologies’s last funding round?
Privo Technologies’s most recent funding round was for $2.5M (USD) in February 2022.
How many employees does Privo Technologies have?
Privo Technologies has 9 employees as of Feb 4, 2024.
How much has Privo Technologies raised to-date?
As of July 05, 2023, Privo Technologies has raised a total of $5.7M (USD) since Feb 25, 2022.
Add Comparison
Total Raised to Date
$5.7M
USD
Last Update Feb 25, 2022
Last Deal Details
$2.5M
USD
Feb 25, 2022
Grant
Total Employees Over Time
9
As of Feb 2024
Privo Technologies Address
200 Corpor
Peabody,
Massachusetts
01960
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts